Indeed, heterogeneous expression of epithelial surface markers has been previously reported in different tumor entities at tissue level [23,24], as well as the loss of EpCAM expression in the case of epithelial-mesenchymal transformation [25,26]. The gene discussed is EPCAM; the disease is neoplasm.